Under fire over high prices, Eli Lilly promised cheaper insulin in 2019. The result has some senators steamed. Sens. Warren and Blumenthal surveyed 400 pharmacies and found a scarcity of the drug giant’s “authorized generic.” 6 years ago National Politics, PoliticsWashington Post Election More Articles: February 15 Taxpayer group urges Trump, Congress to confront rising federal debt February 9 House Oversight probes Rep. Ilhan Omar’s husband’s businesses